HIGHLIGHTS
- who: Louise Thorlacius-Ussing from the University Hospital have published the research: A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia, in the Journal: Scientific Reports Scientific Reports of January/15,/2021
- what: The infusion of convalescent plasma did not influence clinical progression, survival, or length of hospitalization in patients with COVID-19 pneumonia when administered during hospital admission.
- how: With the original primary outcome the trial was designed to enroll 1100 participants. In the revised version the trial was designed to enroll 530 patients (353 in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.